Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece

NCT ID: NCT01957553

Last Updated: 2014-09-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the current investigation is to investigate the performance of a new 2-piece ostomy product

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present investigation aims at testing the performance and safety of a new 2-piece ostomy product.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy - Stoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment sequence 1, First Coloplast Test product

Subjects first allocated to Coloplast Test product will after cross-over test SenSura

Group Type EXPERIMENTAL

Coloplast test product

Intervention Type DEVICE

Coloplast test product is a newly developed 2-piece ostomy appliance

SenSura

Intervention Type DEVICE

SenSura is the commercial available CE-marked SenSura Click 2-piece ostomy appliance from Coloplast A/S

Treatment seqence 2; First SenSura

Subjects first allocated to SenSura will after cross-over test Coloplast Test product

Group Type EXPERIMENTAL

Coloplast test product

Intervention Type DEVICE

Coloplast test product is a newly developed 2-piece ostomy appliance

SenSura

Intervention Type DEVICE

SenSura is the commercial available CE-marked SenSura Click 2-piece ostomy appliance from Coloplast A/S

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coloplast test product

Coloplast test product is a newly developed 2-piece ostomy appliance

Intervention Type DEVICE

SenSura

SenSura is the commercial available CE-marked SenSura Click 2-piece ostomy appliance from Coloplast A/S

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SenSura Click SenSura Standard 2-piece

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.Have given written informed consent and letter of authority (DK only)
* 2.Be at least 18 years of age and have full legal capacity.
* 3.Be able to handle the products her/himself
* 4.Have an ileostomy with a diameter between 10 and 40 mm.
* 5.Have had their ostomy for at least three months.
* 6.Be willing to use minimum 2 base plates every week
* 7.Currently use 2-piece flat mechanical coupling product with open bag 8
* 11.Negative result of a pregnancy test for women of childbearing age (only DK)

Exclusion Criteria

* 1.Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
* 2.Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment.
* 3.Is pregnant or breastfeeding.
* 4.Is participating in other interventional clinical investigations or have previously participated in this investigation
* 5.Has participated in the previous explorative study CP234
* 6\.
* 7.Known hypersensitivity towards any of the test products
* 8.Currently suffering from peristomal skin problems (i.e.bleeding or red and broken skin)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Birte P Jakobsen, MD

Role: PRINCIPAL_INVESTIGATOR

Coloplast A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Imelda Hospital Bonheiden

Bonheiden, , Belgium

Site Status

Aabenraa Stomi Ambulatorie, Sygehus Sønderjylland

Aabenraa, , Denmark

Site Status

Coloplast A/S

Humlebæk, , Denmark

Site Status

Stomiambulatoriet, Kolding Sygehus

Kolding, , Denmark

Site Status

Stomiambulatoriet A5, Odense Hospital

Odense C, , Denmark

Site Status

Kirurgisk ambulatorium/Stomiambulatoriet OUH

Svendborg, , Denmark

Site Status

Vejle Sygehus, Stomiambulatoriet B120

Vejle, , Denmark

Site Status

QPS Netherlands

Groningen, , Netherlands

Site Status

Gastrokirurgisk Sekjon, Kirurgisk Klinikk Haugesund Sjukhus

Haugesund, , Norway

Site Status

Helse Nordbyen

Larvik, , Norway

Site Status

Länssjukhhuset gävle, Stomimottagningen

Gävle, , Sweden

Site Status

Kirug kliniken Centralsjukhuset

Karlstad, , Sweden

Site Status

Kirurgens Mottagning

Malmo, , Sweden

Site Status

Capio St. Görans Sjukhus AB, kirurgkliniken

Stockholm, , Sweden

Site Status

Södersjukhuset

Stockholm, , Sweden

Site Status

karolinska Universitetssjukhuset Solna Stomimottagningen

Stockholm, , Sweden

Site Status

Stomimottagningen Centrllasarette i Västerås

Västerås, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Denmark Netherlands Norway Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP243

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP376 OCT Exploratory Skin Study
NCT06965140 COMPLETED NA
Feasibility Study of a New Fistula Pouching System
NCT00294450 COMPLETED PHASE2/PHASE3